AVR 0.00% $12.00 anteris technologies ltd

allied herpes vaccine phase i trial update, page-2

  1. 177 Posts.
    lightbulb Created with Sketch. 21
    "no safety issues raised." - tick
    "Currently there is no curative treatment for herpes and there is a major unmet medical need" - tick
    "our herpes therapeutic vaccine has huge market potential" - tick tick tick
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.